Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-000838-12Phase 2Completed
Phase 2, open-label, single-arm trial of capsaicin in Vitiligo, sponsored by Medical University of Graz. Primary endpoints: Area of repigmentation and Intensity of repigmentation. Started Jun 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-000838-12.